Skip to main content
. Author manuscript; available in PMC: 2019 Jan 24.
Published in final edited form as: Ther Drug Monit. 2018 Feb;40(1):17–37. doi: 10.1097/FTD.0000000000000462

FIGURE 3.

FIGURE 3.

Saliva–plasma or saliva–serum ratios of anti-TB drugs. Top left: isoniazid; top right: rifampicin; middle left: moxifloxacin; middle right: ofloxacin; bottom left: clarithromycin; and bottom right: gatifloxacin. As per drug, the saliva–plasma or saliva–serum ratios of the included articles are displayed as weighted mean () with range. In addition, the overall mean (♦) and range were determined for each drug. All numerical values of mean and range are presented to the right of the graphs.